Home/Directory/Contract Development & Manufacturing/Syngene International (US)

Syngene International (US)

Amherst, NY (US); Bangalore, India (HQ) · United States

Contract Development & Manufacturinglarge

Specialization: Integrated discovery, development, manufacturing

Key Differentiator

CRDMO arm of Biocon

Core Services

Monoclonal antibody manufacturing; Large molecule drug substance development & manufacturing; Single-use bioreactor technology; Contract research & development

Capabilities

Monoclonal antibody manufacturingLarge molecule drug substance development & manufacturingSingle use bioreactor technologyContract research & development

Market Intelligence

CRDMO arm of Biocon. First US acquisition establishes onshore biologics manufacturing. Retains Emergent offtake rights for future pandemic response. Also serves animal health segment. Strategic US market entry play.

Website

https://www.syngeneintl.com

Similar Companies

AGC Biologics

Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·

Proprietary CHEF1® expression system

ARSI Canada Inc.

Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development

Mississauga CRO

Actylis (Montreal Operations)

Quebec ·

Global API and excipient supplier with Canadian manufacturing

Ajinomoto Bio-Pharma Services

San Diego, CA; Oss, Netherlands ·

Proprietary AJICAP™ site-specific ADC bioconjugation technology

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.